e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Pulmonary fibrosis and pleural disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Recruitment and functions of pulmonary intravascular macrophages (PIMs) in biliary cirrhosis
S. Gill, K. Janardhan, T. Duke, B. Singh (Saskatoon, Canada)
Source:
Annual Congress 2005 - Pulmonary fibrosis and pleural disease
Session:
Pulmonary fibrosis and pleural disease
Session type:
Thematic Poster Session
Number:
3560
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Gill, K. Janardhan, T. Duke, B. Singh (Saskatoon, Canada). Recruitment and functions of pulmonary intravascular macrophages (PIMs) in biliary cirrhosis. Eur Respir J 2005; 26: Suppl. 49, 3560
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Inhibition of acute lung inflammation by removal of pulmonary intravascular macrophages (PIMs)
Source: Eur Respir J 2001; 18: Suppl. 33, 79s
Year: 2001
Resident pulmonary intravascular macrophages (PIMs) are pro-inflammatory while recruited PIMs are anti-inflammatory
Source: Eur Respir J 2002; 20: Suppl. 38, 481s
Year: 2002
Evaluation of neutrophils phagocytosis and killing in pulmonary cystic fibrosis patients
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Pulmonary intravascular macrophages (PIMs) are recruited following exposure to swine barn air and enhance susceptibility to acute lung inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 347s
Year: 2003
Impairment of membranous and vascular components of pulmonary diffusion and plasma endothelin-1 in patients with liver cirrhosis with and without COPD
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009
M2 polarized alveolar macrophages in pulmonary fibrosis
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
A comparison of 99mTc-DTPA clearance and translocation of nano particles in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease
Year: 2020
Evaluation of pulmonary function and functional capacity in patients with liver cirrhosis
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Clinical and functional features in idiopathic pulmonary fibrosis (IPF) with and without haemosiderin-laden alveolar macrophages on BALF
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS)
Source: Eur Respir J 2006; 28: Suppl. 50, 354s
Year: 2006
Increased apoptosis of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF). Potential mechanisms and practical considerations
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Study of the system of hemostasis in patients with chronic forms of pulmonary sarcoidosis (PS) with impairments of regional pulmonary blood circulation
Source: Eur Respir J 2006; 28: Suppl. 50, 537s
Year: 2006
Neutrophil chemotaxis and adhesion in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2001; 18: Suppl. 33, 108s
Year: 2001
Lung involvement in primary biliary cholangitis (PBC)
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Time-course changes in pulmonary haemodynamics in patients with idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation (LT)
Source: Eur Respir J 2004; 24: Suppl. 48, 668s
Year: 2004
Cytokines, chemokines and growth factors concentration in BAL fluid from patients with Idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP)
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
PET-CT with
18
F-FDG and
18
F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Mechanism of bronchoalveolar duct junction (BADJ) remodeling in idiopathic pulmonary fibrosis (IPF) as base for new pathogenetic therapy
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept